^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MIR330 (MicroRNA 330)

i
Other names: MIR330, MicroRNA 330, Hsa-MiR-330-5p, Hsa-MiR-330-3p, Hsa-Mir-330, MIRN330, Hsa-Mir-330-V1_pre, Hsa-Mir-330-V2_pre, MIMAT0000751, MIMAT0004693, MI0000803, Mir-330, RF00770
Associations
Trials
12d
Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer. (PubMed, BMC Cancer)
miR-330-5p was shown to affect the proliferation, invasion, and migration of gastric cancer cells by mediating ITGA5 through a mechanism possibly associated with the regulation of the FAK/AKT signaling pathway.
Journal
|
MIR152 (MicroRNA 152) • ITGA5 (Integrin Subunit Alpha 5) • MIR148A (MicroRNA 148a) • MIR148B (MicroRNA 148b) • MIR26A1 (MicroRNA 26a-1) • MIR330 (MicroRNA 330)
7ms
METTL3-mediated circ_0003998 serves as oncogene in non-small cell lung cancer through regulating miR-330-5p/CXCL3 axis. (PubMed, Cell Cycle)
Also, METTL3 promoted the expression of circ_0003998 by m6A modification. METTL3-modified circ_0003998 promoted NSCLC cell malignancy through miR-330-5p/CXCL3 axis, suggesting that circ_0003998 might be a new treatment strategy for NSCLC.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • CXCL3 (C-X-C Motif Chemokine Ligand 3) • METTL3 (Methyltransferase Like 3) • MIR330 (MicroRNA 330)
8ms
Role of mast cell-derived exosomes in exacerbating neuronal injury of experimental cerebral malaria. (PubMed, Parasit Vectors)
Mast cell-derived exosomes, particularly those from activated cells (AE), exacerbated ECM neuronal injury through partial activation of ER stress pathways.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • MIR155 (MicroRNA 155) • CD9 (CD9 Molecule) • HSPA5 (Heat Shock Protein Family A (Hsp70) Member 5) • MIR192 (MicroRNA 192) • ERN1 (Endoplasmic Reticulum To Nucleus Signaling 1) • IL1B (Interleukin 1, beta) • miR-185 (MicroRNA 185) • CD81 (CD81 Molecule) • MIR187 (MicroRNA 187) • MIR188 (MicroRNA 188) • MIR330 (MicroRNA 330) • MIR423 (MicroRNA 423)
8ms
Journal
|
BMI1 (BMI1 proto-oncogene, polycomb ring finger) • MIR330 (MicroRNA 330)
8ms
Omics Study of Ovarian Malignancies: From Urine Metabolomic Profile to Minimally Invasive MicroRNA Markers (PubMed, Mol Biol (Mosk))
Thus, significant metabolomic imbalance in the urine was observed in the OC patients and was associated with changes in the levels of microRNAs that regulate the signaling pathways of the metabolites. The 26 compounds with abnormal concentrations and the levels of the microRNAs miR-33b-5p, miR-423-5p, miR-6843-3p, miR-4668-3p, miR-30c-5p, miR-6743-5p, miR-4742-5p, miR-1207-5p, and miR-17-5p in the urine were considered to be suitable as noninvasive diagnostic markers of OC.
Journal • Metabolomic study
|
MIR27A (MicroRNA 27a) • MIR17 (MicroRNA 17) • MIR23A (MicroRNA 23a) • MIR370 (MicroRNA 370) • MIR1207 (MicroRNA 1207) • MIR181A1 (MicroRNA 181a-1) • MIR181B1 (MicroRNA 181b-1) • MIR196B (MicroRNA 196b) • MIR19A (MicroRNA 19a) • MIR208A (MicroRNA 208a) • MIR29A (MicroRNA 29a) • MIR30C • MIR330 (MicroRNA 330) • MIR423 (MicroRNA 423) • MIR4742 (MicroRNA 4742) • MIR653 (MicroRNA 653) • MIRLET7B (MicroRNA Let-7b)
8ms
The role and prognostic value of PANoptosis-related genes in skin cutaneous melanoma. (PubMed, Front Immunol)
RT - qPCR validation confirmed significant expression differences of CD8A, ADAMDEC1, CD69, CRIP1, and BCL11B between SKCM and control samples. This study presents a robust prognostic model for SKCM based on PANoptosis - related genes, providing a theoretical foundation for SKCM treatment.
Journal
|
CD8 (cluster of differentiation 8) • CD69 (CD69 Molecule) • CCR7 (Chemokine (C-C motif) receptor 7) • BCL11B (BAF Chromatin Remodeling Complex Subunit BCL11B) • CRIP1 (Cysteine Rich Protein 1) • MIR330 (MicroRNA 330)
8ms
circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis. (PubMed, Hereditas)
The circ-NOLC1 inhibits CC development through regulating the miR-330-5p-PALM signaling axis. This finding reveals a novel mechanism and identifies potential therapeutic targets, emphasizing the necessity for further regulatory studies and clinical validation.
Journal
|
MIR330 (MicroRNA 330)
8ms
Abnormal expression of miR-330-3p predicts post-prostatectomy urinary incontinence and regulates the function of urethral fibroblasts by targeting MMP2. (PubMed, Hereditas)
miR-330-3p is a potential biomarker for PPUI and regulates the function of urethral fibroblasts by targeting MMP2.
Journal
|
MMP2 (Matrix metallopeptidase 2) • IL1B (Interleukin 1, beta) • MIR330 (MicroRNA 330)
9ms
RETRACTION: MiR-330 Suppresses EMT and Induces Apoptosis by Downregulating HMGA2 in Human Colorectal Cancer. (PubMed, J Cell Physiol)
Accordingly, the article is retracted as the editors consider its conclusions to be invalid. The authors have been informed of the decision of retraction but not available for a final confirmation.
Journal
|
HMGA2 (High mobility group AT-hook 2) • MIR330 (MicroRNA 330)
10ms
Hsa_circ_0007905 as a modulator of miR-330-5p and VDAC1: Enhancing stemness and reducing apoptosis in cervical cancer stem cells. (PubMed, Gen Physiol Biophys)
Overexpressing VDAC1 or inhibiting miR-330-5p blocked the roles of silencing hsa_circ_0007905 on CSCs. Thus, we revealed the mechanism by which hsa_circ_0007905 competitively adsorbs miR-330-5p to mediate VDAC1 expression to promote stemness and inhibit apoptosis of CSCs in CC, offering an therapeutic target for treating CC.
Journal
|
MIR330 (MicroRNA 330) • VDAC1 (Voltage Dependent Anion Channel 1)